Aselage Steve's Form 4 filing
Acer Therapeutics Inc. (ACER) · filed Dec 13, 2021
- Accession no.
- 0001209191-21-069227
- Filed
- Dec 13, 2021
- Trade date
- Dec 9-10, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $20.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Aselage SteveCIK 0001221599 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 9, 2021 | Common Stock | PPurchaseAcquired | +2,016 | $2.15 | +$4,334.4 | 65,921 | Direct | |
| Dec 10, 2021 | Common Stock | PPurchaseAcquired | +7,984 | $2.04 | +$16,287.36 | 73,905 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.